Loomis, Sayles & Company
IMCR icon

Loomis, Sayles & Company’s Immunocore IMCR Stock Holding History

Loomis, Sayles & Company’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-301,815
Closed -$10.2M – 716
2024
Q2 		$10.2M Buy
301,815
+282,817
+1,489% +$9.58M 0.01% 354
2024
Q1 		$1.23M Buy
+18,998
New +$1.23M ﹤0.01% 454